Back

Cardiac reverse remodeling induced by cardiac resynchronization therapy results in distinct changes in myocardial work when compared to guideline directed medical therapy

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: HFrEF: pathophysiological insights Ventricular Remodelling ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Karin Ljung

Karolinska Institute, Stockholm (Sweden)

8 More presentations in this session

Presentation thumbnail
Risk stratification with ultrasound markers of congestion in advanced heart failure
Professor H. Sisakian (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Endothelial dysfunction in HFrEF: investigating the role of red blood cells and guideline directed medical therapy
Doctor U. Reistam (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of sacubitril valsartan on sleep apnea in heart failure patients with reduced ejection fraction (SV-SLEEP): a systematic review and meta-analysis
Doctor F. Al-Kindi (Muscat, OM)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of angiography-derived index of microcirculatory resistance in patients with dilated cardiomyopathy
Doctor T. Kawamura (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Changes in left ventricular ejection fraction in patients undergoing transcatheter aortic valve implantation: insights from the COMPARE-TAVI 1 study
Doctor P. Kumarathurai (Odense, DK)
Abstract Slides Video

Access the full session

Session thumbnail
HFrEF: pathophysiological insights

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between left ventricular reverse remodeling and guideline-directed medical therapy intensity in de novo heart failure with reduced ejection fraction patients: insight from TRANS-HF trial
thumbnail
Congress Presentation
Association of echocardiography-derived hemodynamic force parameters with left ventricular reverse remodeling after cardiac resynchronization in non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Cardiac reverse remodeling in the trial of accelerated guideline-directed medical therapy for Heart Failure (TEAM-HF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources